Evidence map›Paper›PMID 41663808›Full record

ArticleNature genetics2026

Author Correction: Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.

Guocan Wang, Andrea Lunardi, Jiangwen Zhang, Zhenbang Chen, Ugo Ala, Kaitlyn A Webster, Yvonne Tay, Enrique Gonzalez-Billalabeitia, Ainara Egia, David R Shaffer and 9 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Guocan Wang *Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Andrea Lunardi *Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Jiangwen ZhangFaculty of Arts and Sciences Center for Systems Biology, Harvard University, Cambridge, Massachusetts, USA.
Zhenbang ChenCancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Ugo AlaCancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Kaitlyn A WebsterCancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Yvonne TayCancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Enrique Gonzalez-BillalabeitiaCancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Ainara EgiaCancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
David R ShafferCancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Brett CarverHuman Oncology and Pathogenesis Program, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Xue-Song LiuCancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Riccardo TaulliCancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Winston Patrick KuoDepartment of Developmental Biology, Harvard School Of Dental Medicine, Boston, Massachusetts, USA.
Caterina NardellaCancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Sabina SignorettiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Carlos Cordon-CardoDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
William L GeraldDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Pier Paolo PandolfiCancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA. ppandolf@bidmc.harvard.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41663808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.